CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders-Reference-Cited by-同舟云学术

CSF α-Synuclein Seed Amplification Assay in Patients With Atypical Parkinsonian Disorders

Published:2024-09-24 Issue:6 Volume:103 Page:
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Anastassiadis Chloe¹,Martinez-Valbuena Ivan¹^ORCID,Vasilevskaya Anna¹,Thapa Simrika¹,Hadian Mohsen¹^ORCID,Morales-Rivero Alonso¹^ORCID,Mora-Fisher Daniela¹,Salvo Cristina¹,Taghdiri Foad¹^ORCID,Sato Christine¹,Moreno Danielle¹^ORCID,Anor Cassandra J.¹,Misquitta Karen¹^ORCID,Couto Blas¹^ORCID,Tang-Wai David F.¹^ORCID,Lang Anthony E.¹^ORCID,Fox Susan H.¹^ORCID,Rogaeva Ekaterina¹^ORCID,Kovacs Gabor G.¹^ORCID,Tartaglia Maria Carmela¹^ORCID

Affiliation:

1. From the Tanz Centre for Research in Neurodegenerative Diseases (C.A., I.M.-V., A.V., S.T., M.H., F.T., C. Sato, D.M., C.J.A., K.M., A.E.L., E.R., G.G.K., M.C.T.); Krembil Brain Institute (I.M.-V., A.M.-R., B.C., D.F.T.-W., A.E.L., S.H.F., G.G.K., M.C.T.); The Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic (I.M.-V., A.M.-R., B.C., A.E.L., S.H.F., G.G.K., M.C.T.); Rossy Progressive Supranuclear Palsy Centre (I.M.-V., A.M.-R., A.E.L., G.G.K., M.C...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Link

https://www.neurology.org/doi/pdfdirect/10.1212/WNL.0000000000209818

Reference51 articles.

1. Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes

2. The Future of Seed Amplification Assays and Clinical Trials

3. Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated

4. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

5. Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy